Summary
Since the sixties, t h e emergence of malarial parasites resistant to the most potent anti-malarials has posed a serious problem to the therapy of malaria. Qinghaosu, a new sesquiterpene isolated from a Chinese medicinal herb Qing-hao (Artemisia a n n u a Linn) is being used for the treatment of malaria in China with good results even in cases resistant to common anti-malarial agents. In this paper, a sensitive method of high specificity using TLC for the determination of Qinghaosu in biological specimens and in the study of the metabolism of the drug in rats is described.
Qinghaosu was shown to be completely and rapidly absorbed after oral administration. However, a very low plasma level was obtained even after a dose of 300 mg/kg. Liver was found to be the chief site of its inactivation. When Qinghaisu was given intramuscularly, significant and more persistent plasma levels were detected. Qinghaosu was shown to pass the blood-brain a n d blood-placenta barriers after i.v. injection. Very little unchanged Qinghaosu was found in the urine a n d feces in 48 hours regardless of administration route (i.v., i.m. or p.o.).
Similar content being viewed by others
References
Qinghaosu Antimalaria Coordinating Research Group (1979): Antimalaria studies on Qinghaosu, Chinese Med. J.,92, 811–816.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xinyi, N., Liyi, H., Zhihong, R. et al. Metabolic fate of Qinghaosu in rats; A new TLC densitometric method for its determination in biological material. European Journal of Drug Metabolism and Pharmacokinetics 10, 55–59 (1985). https://doi.org/10.1007/BF03189697
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189697